Evaluation of Suspected Rheumatic Disease


Rheumatic diseases are defined by the constellation of results of the physical examination, autoimmune marker and other serologic tests, tissue pathology, and imaging. Defined diagnostic criteria exist for most rheumatic diseases. Recognition of clinical patterns remains essential for diagnosis because there is no single diagnostic test, and results may be positive in the absence of disease. Further complicating the diagnosis, children sometimes present with partial criteria that evolve over time or with features of more than one rheumatic disease ( overlap syndromes ). The primary mimics of rheumatic diseases are infection and malignancy but also include metabolic, orthopedic, immune deficiencies, autoinflammatory diseases, and chronic pain conditions. Exclusion of possible mimicking disorders is essential before initiation of treatment for a presumptive diagnosis, especially corticosteroids. After careful evaluation has excluded nonrheumatic causes, referral to a pediatric rheumatologist for confirmation of the diagnosis and treatment should be considered.

Symptoms Suggestive of Rheumatic Disease

There are no classic symptoms of a rheumatic disease, but common symptoms include joint pain, fever, fatigue, and rash. Presenting signs and symptoms help direct the evaluation and limit unnecessary testing. Once a differential diagnosis is developed on the basis of history and physical findings, a directed assessment assists in determining the diagnosis.

Arthralgias are common in childhood and are a frequent reason for referral to pediatric rheumatologists. Arthralgias without physical findings for arthritis suggest infection, malignancy, orthopedic conditions, benign syndromes, or pain syndromes such as fibromyalgia ( Table 178.1 ). Although rheumatic diseases may manifest as arthralgias, arthritis is a stronger predictor of the presence of rheumatic disease and a reason for referral to a pediatric rheumatologist. The timing of joint pain along with associated symptoms, including poor sleep and interference with normal activities, provides important clues. Poor sleep, debilitating generalized joint pain that worsens with activity, school absences, and normal physical and laboratory findings in an adolescent suggest a pain syndrome (e.g., fibromyalgia). If arthralgia is accompanied by a history of dry skin, hair loss, fatigue, growth disturbance, or cold intolerance, testing for thyroid disease is merited. Nighttime awakenings because of severe pain along with decreased platelet or white blood cell count or, alternatively, a very high WBC count, may lead to the diagnosis of malignancy, especially marrow-occupying lesions such as acute lymphocytic leukemia and neuroblastoma . Pain with physical activity suggests a mechanical problem such as an overuse syndrome or orthopedic condition. An adolescent girl presenting with knee pain aggravated by walking up stairs and on patellar distraction likely has patellofemoral syndrome . Children age 3-10 yr who have a history of episodic pain that occurs at night after increased daytime physical activity that is relieved by rubbing, but who have no limp or complaints in the morning, likely have growing pains . There is often a positive family history for growing pains, which may aid in this diagnosis. Intermittent pain in a child, especially a girl 3-10 yr old, that is increased with activity and is associated with hyperextensible joints on examination, is likely benign hypermobility syndrome . Many febrile illnesses cause arthralgias that improve when the temperature normalizes, and arthralgias are part of the diagnostic criteria for acute rheumatic fever ( ARF ; see Chapter 210.1 ).

Table 178.1
Symptoms Suggestive of Rheumatic Disease
SYMPTOM RHEUMATIC DISEASE(S) POSSIBLE NONRHEUMATIC DISEASES CAUSING SIMILAR SYMPTOMS
Fevers Systemic JIA, SLE, vasculitis, acute rheumatic fever, sarcoidosis, MCTD Malignancies, infections and postinfectious syndromes, inflammatory bowel disease, periodic fever (autoinflammatory) syndromes, Kawasaki disease, HSP
Arthralgias JIA, SLE, rheumatic fever, JDM, vasculitis, scleroderma, sarcoidosis Hypothyroidism, trauma, endocarditis, other infections, pain syndromes, growing pains, malignancies, overuse syndromes
Weakness JDM, myositis secondary to SLE, MCTD, and deep localized scleroderma Muscular dystrophies, metabolic and other myopathies, hypothyroidism
Chest pain Juvenile idiopathic arthritis, SLE (with associated pericarditis or costochondritis) Costochondritis (isolated), rib fracture, viral pericarditis, panic attack, hyperventilation
Back pain Enthesitis-related arthritis, juvenile ankylosing spondylitis Vertebral compression fracture, diskitis, intraspinal tumor, spondylolysis, spondylolisthesis, bone marrow–occupying malignancy, pain syndromes, osteomyelitis, muscle spasm, injury
Fatigue SLE, JDM, MCTD, vasculitis, JIA Pain syndromes, chronic infections, chronic fatigue syndrome, depression
HSP, Henoch-Schönlein purpura; JDM, juvenile dermatomyositis; JIA, juvenile idiopathic arthritis; MCTD, mixed connective tissue disease; SLE, systemic lupus erythematosus.

Arthralgia may also be a presenting symptom of pediatric systemic lupus erythematosus ( SLE ) and chronic childhood arthritis such as juvenile idiopathic arthritis (JIA). Interestingly, many children with JIA do not complain of joint symptoms at presentation. Other symptoms more suggestive of arthritis include morning stiffness, joint swelling, limited range of motion, pain with joint motion, gait disturbance, fever, and fatigue or stiffness after physical inactivity (gelling phenomenon) . A diagnosis of JIA cannot be made without the finding of arthritis on physical examination (see Chapters 180 and 181 ). No laboratory test is diagnostic of JIA or any other chronic inflammatory arthritis in childhood.

Fatigue is a nonspecific symptom that may point to the presence of a rheumatic disease but is also common in nonrheumatic causes, such as viral infections, pain syndromes, depression, and malignancy. Fatigue, rather than the specific complaints of muscle weakness, is a common presenting complaint in juvenile dermatomyositis (JDM) . It is also frequently present in SLE, vasculitis, and the chronic childhood arthritides. Overwhelming fatigue with inability to attend school is more suggestive of chronic fatigue syndrome, pediatric fibromyalgia, or other amplified pain syndrome.

Signs Suggestive of Rheumatic Disease

A complete physical examination is mandated in any child with suspected rheumatic disease, because many diseases have associated subtle physical findings that will further refine the differential diagnosis. In addition, many rheumatic diseases have multisystem effects, and a stepped assessment should focus on delineating the extent of organ system involvement (e.g., skin, joints, muscle, hepatic, renal, cardiopulmonary).

Presence of a photosensitive malar rash that spares the nasolabial folds is suggestive of SLE ( Table 178.2 ; see Fig. 183.1 A ), especially in an adolescent girl. Diffuse facial rash is more indicative of JDM. A hyperkeratotic rash on the face or around the ears of an adolescent black girl may represent discoid lupus (see Fig. 183.1 D ). A palpable purpuric rash on the extensor surfaces of the lower extremities points to Henoch-Schönlein purpura (see Fig. 192.2 A ). Less localized purpuric rashes and petechiae are present in systemic vasculitis or blood dyscrasias, including coagulopathies. Nonblanching erythematous papules on the palms are seen in vasculitis and SLE as well as endocarditis. Gottron papules (see Fig. 184.2 ) and heliotrope rashes (see Fig. 184.1 ) along with erythematous rashes on the elbows and knees are pathognomonic of JDM. Dilated capillary loops in the nail beds (periungual telangiectasias; see Fig. 184.3 ) are common in JDM, scleroderma, and secondary Raynaud phenomenon. An evanescent macular rash associated with fever is part of the diagnostic criteria for systemic-onset arthritis (see Fig. 180.12 ). Sun sensitivity or photosensitive rashes are indicative of SLE or JDM but can also be caused by antibiotics.

Table 178.2
Signs Suggestive of Rheumatic Disease
SIGN RHEUMATIC DISEASES COMMENTS NONRHEUMATIC CAUSES
Malar rash SLE, JDM SLE classically spares nasolabial folds Sunburn, parvovirus B19 (fifth disease), Kawasaki disease
Oral ulcers SLE, Behçet disease Behçet disease also associated with genital ulcers HSV infection, PFAPA syndrome
Purpuric rash Vasculitis, e.g., ANCA-associated vasculitis, HSP HSP typically starts as small lesions on lower extremities and buttocks that coalesce Meningococcemia, thrombocytopenia, clotting disorders
Gottron papules JDM Look for associated heliotrope rash, periungual telangiectasias Psoriasis, eczema
Arthritis Juvenile idiopathic arthritis, SLE, vasculitis, HSP, MCTD, scleroderma, acute rheumatic fever, reactive arthritis Chronic joint swelling (>6 wk) required for diagnosis of chronic arthritis of childhood; MCTD associated with diffuse puffiness of hands Postviral arthritis, reactive arthritis, trauma, infection, Lyme disease, Kawasaki disease, malignancy, overuse syndromes
ANCA, Antineutrophil cytoplasmic antibody; HSP, Henoch-Schönlein purpura; HSV, herpes simplex virus; JDM, juvenile dermatomyositis; MCTD, mixed connective tissue disease; PFAPA, periodic fever, aphthous stomatitis, pharyngitis, and adenitis; SLE, systemic lupus erythematosus.

Mouth ulcers are part of the diagnostic criteria for SLE and Behçet disease (see Fig. 183.1 C ); painless nasal ulcers and erythematous macules on the hard palate are also common in SLE. Cartilage loss in the nose, causing a saddle nose deformity, is classically present in granulomatosis with polyangiitis (formally Wegener granulomatosis; see Fig. 192.8 ) but is also seen in relapsing polychondritis and syphilis. Alopecia can be associated with SLE but is also found in localized scleroderma (see Fig. 185.4 ) and JDM. Raynaud phenomenon may be a primary benign idiopathic disorder or can be a presenting complaint in the child with scleroderma, lupus, mixed connective tissue disease (MCTD), or an overlap syndrome. Diffuse lymphadenopathy is present in many rheumatic diseases, including SLE, polyarticular JIA, and systemic JIA. Irregular pupils may represent the insidious and unrecognized onset of uveitis associated with JIA. Erythematous conjunctivae may be a result of uveitis or episcleritis associated with JIA, SLE, sarcoidosis, spondyloarthropathies, or vasculitis.

A pericardial rub and orthopnea are suggestive of pericarditis , often seen in systemic JIA, SLE, and sarcoid. Coronary artery dilation is strongly suggestive of Kawasaki disease but may also be a finding in systemic arthritis and other forms of systemic vasculitis. Interstitial lung disease, suggested by dyspnea on exertion or the finding of basilar rales with decreased carbon monoxide diffusion capacity, occurs in SLE, MCTD, and systemic sclerosis. Signs consistent with pulmonary hemorrhage points to granulomatosis with polyangiitis, microscopic angiitis, or SLE. Pulmonary vascular aneurysms are indicative of Behçet disease.

Arthritis is defined by the presence of intraarticular swelling or 2 or more of the following findings on joint examination: pain on motion, loss of motion, erythema, and heat. Arthritis is present in all the chronic childhood arthritis syndromes, along with SLE, JDM, vasculitis, Behçet disease, sarcoidosis, Kawasaki disease, and Henoch-Schönlein purpura. Nonrheumatic causes of arthritis include malignancy, septic arthritis, Lyme disease, osteomyelitis, viral infections (e.g., rubella, hepatitis B, parvovirus B19, chikungunya), and postinfectious etiologies such as Epstein-Barr virus (EBV), ARF, and reactive arthritis. ARF typically involves a migratory (lasting hours to days), painful arthritis. Pain on palpation of long bones is suggestive of malignancy. Specific muscle testing for weakness should be performed in a child presenting with fatigue or difficulty with daily tasks, because both these symptoms may be manifestations of muscle inflammation.

Laboratory Testing

There are no specific screening tests for rheumatologic disease. Once a differential diagnosis is determined, appropriate testing can be performed ( Tables 178.3 and 178.4 ). Initial studies are generally performed in standard local laboratories. Screening for specific autoantibodies can be performed in commercial laboratories, but confirmation of results in a tertiary care center immunology laboratory is often necessary.

Table 178.3
Autoantibody Specificity and Disease Associations
Adapted from Aggerwal A: Clinical application of tests used in rheumatology, Indian J Pediatr 69:889–892, 2002.
ANTIBODY DISEASE PREVALENCE (%) SPECIFICITY
Antinuclear antibody (ANA) SLE, juvenile rheumatoid arthritis, dermatomyositis, scleroderma, psoriatic arthritis, MCTD Associated with increased risk of uveitis in JIA and psoriatic arthritis
Up to 30% of children testing positive for ANAs have no underlying rheumatic disease
Double-stranded DNA (dsDNA) SLE 60-70 High specificity for SLE; associated with lupus nephritis
Smith (Sm) SLE 20-30 Highly specific for SLE; associated with lupus nephritis
Smooth muscle (Sm) Autoimmune hepatitis
Pm-Scl (polymyositis-scleroderma) Sclerodermatomyositis
SSA (Ro) SLE, Sjögren syndrome 25-30 Associated with neonatal lupus syndrome, subacute cutaneous lupus, thrombocytopenia
SSB (La) SLE, Sjögren syndrome 25-30 Usually coexists with anti-SSA antibody
Ribonuclease protein (RNP) MCTD, SLE 30-40 Suggestive of MCTD unless meets criteria for SLE
Histone Drug-induced lupus, SLE
Centromere Limited cutaneous systemic sclerosis 70 Nonspecific for systemic sclerosis
Topoisomerase I (Scl-70) Systemic sclerosis Rare in childhood
Antineutrophil cytoplasmic antibodies (ANCAs) Vasculitis
Cytoplasmic (cANCAs)/PR3-ANCA cANCAs associated with granulomatosis with polyangiitis (Wegener), cystic fibrosis
Perinuclear (pANCAs)/MPO-ANCA pANCAs associated with microscopic polyangiitis, polyarteritis nodosa, SLE, inflammatory bowel disease, cystic fibrosis, primary sclerosing cholangitis, Henoch-Schönlein purpura, Kawasaki disease, Churg-Strauss syndrome
Anticitrullinated protein (ACPA); also called anti–cyclic citrullinated protein (anti-CCP) RF-positive JIA 50-90 Specific for JIA (RF+), may be positive before RF
MCTD, Mixed connective tissue disease; MPO-ANCA, antimyeloperoxidase; PR3-ANCA, antiproteinase 3; RF, rheumatoid factor; SLE, systemic lupus erythematosus.

Table 178.4
Evaluation Based on Suspected Diagnosis of Rheumatic Disease
SUSPECTED RHEUMATIC DISEASE(S) INITIAL EVALUATION FURTHER EVALUATION SUBSPECIALTY EVALUATION
Systemic lupus erythematosus (SLE)
Mixed connective tissue disease (MCTD)
CBC, ESR, ANA, ALT, AST, CPK, creatinine, albumin, total protein, urinalysis, BP, thyroid profile If ANA test result is positive: anti-SSA (Ro), anti-SSB (La), anti-Smith, and anti-RNP Abs; anti-dsDNA Ab, C3, C4, Coombs, spot urine protein/creatinine ratio, CXR Antiphospholipid Abs, lupus anticoagulant, anti–β 2 -glycoprotein, echocardiogram; consider renal biopsy, PFTs, bronchoscopy with lavage, HRCT of chest; consider lung biopsy
Juvenile dermatomyositis (JDM) CBC, CPK, ALT, AST, LDH, aldolase, ANA; check gag reflex Consider MRI of muscle Consider electromyography and possible muscle biopsy, PFTs, swallowing study, serum neopterin
Juvenile idiopathic arthritis (JIA) CBC, ESR, creatinine, ALT, AST, consider anti–streptolysin O/anti–DNAase B for streptococcus-induced arthritis, Epstein-Barr virus titers, Lyme titer, parvovirus B19 titer, plain radiograph of joints Consider Ab titers to unusual infectious agents, purified protein derivative, RF, ANA, HLA-B27, anti-CCP MRI
Granulomatosis with polyangiitis (Wegener granulomatosis) CBC, ANCA, AST, ALT, albumin, creatinine, ESR, urinalysis, CXR, BP Spot urine protein/creatinine ratio, anti–myeloperoxidase and anti–proteinase-3 Abs, PFTs Bronchoscopy with lavage, HRCT chest; consider lung and kidney biopsies
Sarcoidosis CBC, electrolytes, AST, ALT, albumin, creatinine, calcium, phosphorous, ACE, BP CXR, PFTs Consider testing for Blau syndrome in infants (see Chapter 184 ); HRCT of chest; consider renal and lung biopsy
Localized scleroderma Skin biopsy, CBC, ESR Serum IgG, ANA, RF, single-stranded DNA Ab, antihistone Ab, CPK
Systemic scleroderma ANA, CBC, ESR, BP, AST, ALT, CPK, creatinine, CXR Anti-Scl70, PFTs HRCT of chest, echocardiogram, upper GI radiography series
Ab, Antibody; ACE, angiotensin-converting enzyme (normally elevated in childhood; interpret with caution); ALT, alanine transaminase; ANA, antinuclear antibody; anti-dsDNA Ab, anti–double-stranded DNA antibody; AST, aspartate transaminase; BP, blood pressure; CBCD, complete blood count with differential; CCP, cyclic citrullinated protein; CPK, creatine phosphokinase; CXR, chest radiograph; ESR, erythrocyte sedimentation rate; GI, gastrointestinal; HRCT, high-resolution CT; LDH, lactate dehydrogenase; PFTs, pulmonary function tests; RF, rheumatoid factor; RNP, ribonucleoprotein.

One essential laboratory test for rheumatic disease assessment is the complete blood count (CBC), since it yields many diagnostic clues. Elevated WBC count is compatible with malignancy, infection, systemic JIA, and vasculitis. Leukopenia can be postinfectious, especially viral, or caused by SLE or malignancy. Lymphopenia is more specific for SLE than is leukopenia. Platelets are acute-phase reactants and are therefore elevated with inflammatory markers. Exceptions are a bone marrow–occupying malignancy, such as leukemia or neuroblastoma, SLE, and early Kawasaki disease. Anemia is nonspecific and may be caused by any chronic illness, but hemolytic anemia (positive Coombs test result) may point to SLE or MCTD. Rheumatoid factor (RF) is present in <10% of children with JIA and thus has poor sensitivity as a diagnostic tool; RF may be elevated by infections such as endocarditis, tuberculosis, syphilis, and viruses (parvovirus B19, hepatitides B and C, mycoplasma), as well as primary biliary cirrhosis and malignancies. In a child with chronic arthritis, RF serves as a prognostic indicator.

Inflammatory markers (erythrocyte sedimentation rate, C-reactive protein) are nonspecific and are elevated in infections and malignancies as well as rheumatic diseases ( Tables 178.5 and 178.6 ). Their levels may also be normal in rheumatic diseases such as arthritis, scleroderma, and dermatomyositis. Inflammatory marker measurements are more useful in rheumatic diseases for following response to treatment than as diagnostic tests. Muscle enzymes include aspartate transaminase (AST), alanine transaminase (ALT), creatinine phosphokinase (CPK), aldolase, and lactate dehydrogenase (LDH), any of which may be elevated in JDM as well as in other diseases causing muscle breakdown. Muscle-building supplements, medications, and extreme physical activity may also cause muscle breakdown and enzyme elevations. AST, ALT, and aldolase are also elevated secondary to liver disease, and a γ-glutamyltransferase (GGT) measurement may help differentiate whether the source is muscle or liver.

Table 178.5
Comparison of Erythrocyte Sedimentation Rate and C-Reactive Protein
From Firestein GS, Budd RC, Gabriel SE, et al, editors: Kelley & Firestein's textbook of rheumatology, ed 10, Philadelphia, 2017, Elsevier ( Table 57.3 , p 849).
ERYTHROCYTE SEDIMENTATION RATE C-REACTIVE PROTEIN
Advantages Much clinical information in the literature
May reflect overall health status
Rapid response to inflammatory stimuli
Wide range of clinically relevant values are detectable
Unaffected by age and gender
Reflects value of a single acute-phase protein
Can be measured on stored sera
Quantitation is precise and reproducible
Disadvantages Affected by red blood cell morphology
Affected by anemia and polycythemia
Reflects levels of many plasma proteins, not all of which are acute-phase proteins
Responds slowly to inflammatory stimuli
Requires fresh sample
May be affected by drugs (IVIG)
Not sensitive to changes in SLE disease activity
IVIG, Intravenous immune globulin; SLE, systemic lupus erythematosus.

Table 178.6
From Firestein GS, Budd RC, Gabriel SE, et al, editors: Kelley & Firestein's textbook of rheumatology, ed 10, Philadelphia, 2017, Elsevier (Table 57-4, p 849).
Conditions Associated With Elevated C-Reactive Protein Levels

Normal Or Minor Elevation (<1 mg/dL)

  • 1

    Vigorous exercise

  • 2

    Common cold

  • 3

    Pregnancy

  • 4

    Gingivitis

  • 5

    Seizures

  • 6

    Depression

  • 7

    Insulin resistance and diabetes

  • 8

    Several genetic polymorphisms

  • 9

    Obesity

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here